Mitotropic compounds for the treatment of age-related macular degeneration
If IGF-1 remains below the age-adjusted lower quartile and the patient tolerates the dose without fluid retention or glucose elevation, increase to 100 to 150 mcg twice daily
These results provide a cross-model, cross-species atlas of glial states and offer a framework to strategically leverage mouse models to study myelin injury and repair
Stack Purpose : Advanced injury recovery (tendon tears, ligament reconstruction, nerve trauma) Systemic inflammation and soft tissue regeneration Post-surgical protocols Typical stack : BPC-157: 250500 mcg/day (SubQ, near injury) TB-500: 25 mg/week (IM or SubQ, split doses) Duration: 68 weeks The combined use of BPC-157 and TB-500 may promote complementary wound healing mechanismsangiogenesis, fibroblast activation, and myofiber regeneration. Sikiric et al., Current Pharmaceutical Design 2
These future trials would ideally: Test Safety and Effectiveness : Clinical trials could examine the safety of semaglutide for RA patients, especially since RA patients may already be on other medications, like methotrexate or corticosteroids, that can interact with new drugs